Trial Profile

a Phase 2 study of DISC-0974 in anemia of myelofibrosis (MF)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 29 Jan 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Jan 2026 According to a Disc Medicine media release, Updated data from this trial expected in H2 2026, followed by an End of Phase 2 Meeting.
07 Aug 2025 According to a Disc Medicine media release, exploratory cohort for patients on concomitant momelotinib or pacritinib fully enrolled, and trial protocol updated to allow patients on these therapies into the main study cohorts.
07 Aug 2025 According to a Disc Medicine media release, company anticipates initial data from this Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis in Q4 2025.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com